References
- Albanese, M. J., Clodfelter Jr., R. C., Pardo, T. B., Ghaemi, S. N. (2006). Underdiagnosis of bipolar disorder in men with substance use disorder. J Psychiatr Pract, 12, 124–127.
- Cerullo, M. A., Strakowski, S. M. (2007). The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy, 2, 29. doi:10.1186/1747–597X–2–29.
- Gold, M. S., Pottash, A. C., Sweeney, D., Martin, D., Extein, I. (1982). Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence. Ann N Y Acad Sci, 398, 140–150.
- Hirschfeld, R. M. A., Williams, J. B. W., Spitzer, R. L., (2000). Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry, 157, 1873–1875.
- Schaffer, C. B., Nordahl, T. E., Schaffer, L. C., Howe, J. (2007). Mood-elevating effects of opioid analgesics in patients with bipolar disorder. J Neuropsychiatry Clin Neurosci, 19, 449–452.
- Sonne, S. C., Brady, K. T., Morton, W. A. (1994). Substance abuse and bipolar affective disorder. J Nerv Ment Dis, 182, 349–352.
- Strakowski, S. M., DelBello, M. P. (2000). The co-occurrence of bipolar and substance use disorders. Clin Psychol Rev, 20, 191–206.